Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivermectin to Prevent Hospitalizations in COVID-19
NCT04529525Phase 3Completed
- Sponsor
- Instituto de Cardiología de Corrientes
- Start
- Aug 2020
- Primary completion
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of CHILD-IVITAB in coronavirus disease 2019 (COVID-19), sponsored by Instituto de Cardiología de Corrientes. Started Aug 2020; status: completed.
02
Drugs
CHILD-IVITAB
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04529525.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04529525.